22nd Century Group Announces Public Offering of Common Stock
According to a report by Menafn on October 16th, biotechnology company 22nd Century Group has announced plans to publicly offer the sale of its common stock or alternative equivalents, as well as subscription warrants to purchase common stock. All common stock or equivalents, as well as subscription warrants, to be sold in the offering will be issued by 22nd Century Group.
Dawson James Securities has been appointed as the exclusive underwriter for this public offering. The company anticipates utilizing the net proceeds from this issuance for general corporate purposes.
According to reports, 22nd Century Group is a leading biotechnology company dedicated to improving health through advanced plant technologies utilizing reduced nicotine tobacco, cannabis/hemp, and hops. The company secured the first and only Modified Risk Tobacco Product (MRTP) authorization from the US Food and Drug Administration in December 2021 for its tobacco combustion product.
Disclaimer:
This article is translated from an original Chinese article available on 2firsts.cn by AI, and has been reviewed and edited by 2FIRSTS's English editorial team. The Chinese original text is the only authoritative source of information. The exclusive copyright and license rights to this article are held by 2FIRSTS Technology Co., Ltd. Any reproduction, reprinting, or redistribution of this article, either in part or in full, requires express written permission from 2FIRSTS and must include clear attribution along with a link to this content. Non-compliance may result in legal action. 2FIRSTS Technology Co., Ltd. reserves the right to pursue legal actions in case of unauthorized use or distribution.
